DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Afimoxifene is an investigational drug.
There have been 5 clinical trials for Afimoxifene. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2003.
The most common disease conditions in clinical trials are Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal, Breast, and Carcinoma in Situ. The leading clinical trial sponsors are National Cancer Institute (NCI), Northwestern University, and BHR Pharma, LLC.
Recent Clinical Trials for Afimoxifene
|Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast||National Cancer Institute (NCI)||Phase 2|
|Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast||Northwestern University||Phase 2|
|Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast||BHR Pharma, LLC||Phase 2|